Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKZF2 | Q9UKS7 | 11/20 | 0.60 |
| ▸ | CRBN | Q96SW2 | 9/20 | 0.56 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23250036 | 0.82 | CRBN (0.62) | IKZF2CRBNCSNK1A1 | |
| SCHEMBL29873934 | 0.82 | CRBN (0.62) | IKZF2CRBNCSNK1A1 | |
| SCHEMBL30569130 | 0.81 | CRBN (0.69) | IKZF2CRBNCSNK1A1 | |
| SCHEMBL24637376 | 0.81 | CRBN (0.69) | IKZF2CRBNCSNK1A1 | |
| SCHEMBL25210909 | 0.81 | IKZF2 (0.61) | IKZF2CRBNCSNK1A1 | |
| SCHEMBL30416805 | 0.81 | IKZF2 (0.61) | IKZF2CRBNCSNK1A1 | |
| SCHEMBL23267271 | 0.79 | CRBN (0.64) | IKZF2CRBNCSNK1A1 | |
| SCHEMBL21877059 | 0.79 | CRBN (0.64) | IKZF2CRBNCSNK1A1 | |
| SCHEMBL21760044 | 0.78 | CRBN (0.69) | IKZF2CRBNCSNK1A1 | |
| SCHEMBL24601235 | 0.78 | CRBN (0.69) | IKZF2CRBNCSNK1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240383908-A1 | SYNTHESIS AND APPLICATION OF PHOSPHATASE DEGRADER | HINOVA PHARMACEUTICALS INC. (CN) | 2024-11-21 | — | — | US | disclosed |
| EP-4368614-A1 | SYNTHESIS AND APPLICATION OF PHOSPHATASE DEGRADER | Hinova Pharmaceuticals Inc. (CN) | 2024-05-15 | — | — | EP | disclosed |
| WO-2023280237-A1 | SYNTHESIS AND APPLICATION OF PHOSPHATASE DEGRADER | 海创药业股份有限公司 | 2023-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240383908-A1 | SYNTHESIS AND APPLICATION OF PHOSPHATASE DEGRADER | DUSP1, PPM1D, PTPN1 | IKZF2 1349/4885CRBN 576/4885CSNK1A1 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.